Literature DB >> 15806409

[Implant infections. What must an internist know?].

W Zimmerli1.   

Abstract

Implant-associated infections are a major challenge for the primary care physician because the chance of cure depends on the time interval between infection and start of adequate surgical and antimicrobial treatment. On the other hand, rapid therapy should not prevent from correct microbiological sampling. Since long-term antibiotic therapy is required, the microorganism and its susceptibility pattern should be known. Thus, the primary care physician should know signs and symptoms of these rare infections and rapidly involve the specialist. The main task of the specialist is to confirm the diagnosis and to decide whether the implant has to be removed, or whether debridement with retention is a feasible option to eradicate infection. In this review, infections associated to vascular grafts, to pacemakers and to arthroplasties are presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806409     DOI: 10.1007/s00108-005-1401-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  Pacemaker lead infection: echocardiographic features, management, and outcome.

Authors:  F Victor; C De Place; C Camus; H Le Breton; C Leclercq; D Pavin; P Mabo; C Daubert
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

Review 2.  Prosthetic vascular graft infection.

Authors:  T O'Brien; J Collin
Journal:  Br J Surg       Date:  1992-12       Impact factor: 6.939

3.  Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces.

Authors:  P Vaudaux
Journal:  Drug Resist Updat       Date:  1998       Impact factor: 18.500

4.  Pacemaker infective endocarditis.

Authors:  P Cacoub; P Leprince; P Nataf; P Hausfater; R Dorent; B Wechsler; V Bors; A Pavie; J C Piette; I Gandjbakhch
Journal:  Am J Cardiol       Date:  1998-08-15       Impact factor: 2.778

5.  Management of infection associated with total hip arthroplasty according to a treatment algorithm.

Authors:  S G Giulieri; P Graber; P E Ochsner; W Zimmerli
Journal:  Infection       Date:  2004-08       Impact factor: 3.553

6.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus.

Authors:  W Zimmerli; R Frei; A F Widmer; Z Rajacic
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

Review 7.  Management of infected aortic prosthetic grafts.

Authors:  Timothy W Swain; Keith D Calligaro; Matthew D Dougherty
Journal:  Vasc Endovascular Surg       Date:  2004 Jan-Feb       Impact factor: 1.089

Review 8.  Management of infected aortic grafts.

Authors:  P F Lawrence
Journal:  Surg Clin North Am       Date:  1995-08       Impact factor: 2.741

9.  Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.

Authors:  H J Trappe; P Pfitzner; H Klein; P Wenzlaff
Journal:  Br Heart J       Date:  1995-01

10.  Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.

Authors:  D P Zipes; D Roberts
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.